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Purpose: Invasive breast carcinoma is the most common cancer in women as in non-ovariectomised pet dogs,
which are already identified as a valuable spontaneous preclinical model for that disease. Geographical and time
trends suggest that environmental factors may play an important role in the etiology and pathogenesis of breast
cancer. Persistent organic pollutants (POPs) fit perfectly with these trends and are known to interact with hormonal
receptors implicated in breast cancer subtyping. The aim of this innovating study was to evaluate the interest of
the companion dog model in assessing chemical exposure and breast cancer associations, in order to identify
common etiological features with the human disease in a context of comparative oncology.
Methods: We monitored a hundred of molecules belonging to a large panel of POPs (dioxins, dioxin-like and non
dioxin-like polychlorobisphenyls, organochlorine pesticides, brominated flame retardants, perfluorinated alkylated
substances) in companion dogs diagnosed for mammary adenocarcinoma (n = 54) and non cancer controls (n = 47).
Results: All targeted chemical families were able to be detected in canine samples. We identified pollutants
associated with mammary cancer belonging to the dioxin like-PCB family (notably PCB-118, -156, -105, -114) that
were already pointed out in human epidemiological studies on breast cancer, and that fit with the fundamental role
of the Aryl Hydrocarbon Receptor in the promotion of breast cancer.
Conclusions: Similarities observed in the spontaneous dog model are very helpful to progress in interpretation of
human breast cancer-environment relationships. This study provides a new insight focusing on this discrete but
recurrent signature.
Keywords: Breast cancer; Comparative oncology; Dog model; Persistent organic pollutants; Aryl hydrocarbon
receptor; EtiologyIntroduction
Parallel observations can be made during the last
decades regarding an increased environmental chemical
pollution and an increased incidence of breast cancer
over the same period in industrialized countries.
Geographical variations, time trends, and studies of
populations migrating from low to high risk areas
(with migrants approaching the risk of the host
country in one or two generations) clearly suggest an
important role of environmental factors in the etiology* Correspondence: sabine.severe@oniris-nantes.fr
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in any medium, provided the original work is pof the disease. Although less commonly reported, the
incidence of cancers and especially mammary (breast)
cancer in pets is also increasing. Many spontaneous
canine cancers are homologous to their human
counterparts, regarding phenotypic but also molecular
aspects (Khanna et al. 2006; Paoloni and Khanna 2008;
Pinho et al. 2012). In particular for mammary cancer,
biological characteristics, classifications and pathological
subtypes are extremely comparable in the two species
(Uva et al. 2009; Rivera and von Euler 2011; Kim et al.
2013). Breast cancer subtypes are classified depending on
hormonal receptor patterns expression (Guedj et al. 2012),
namely the estrogen (ER), progesterone (PR) and
androgen (AR) receptors. Persistent organic pollutants
(POPs) are able to interact with these hormonal nuclearn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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way with some exceptions, organochlorine pesticides
(OCPs), non-dioxin like polychlorobisphenyl (ndl-PCB)
congeners, brominated flame retardants (BFRs) and
perfluorinated alkylated substances (PFAS) are able to
generate agonist or antagonist interactions with ER,
AR and PR (Hamers et al. 2006; Lundholm 1988;
Maras et al. 2006; Nelson 1974; Sohoni and Sumpter
1998). Dioxins (PCDD/Fs) and dioxin-like PCBs (dl-PCB)
target mainly the aryl hydrocarbon receptor (AhR)
(Kafafi et al. 1993; Kouri et al. 1974), which is implicated
in the down-regulation of ER and AR expression at both
genetic and molecular level (Ohtake et al. 2011). All these
POPs are proved to be present in human as in dog blood
and adipose tissues where they are stored predominantly,
and to be transmitted to offspring through umbilical cord
and maternal milk (Antignac et al. 2009; Den Hond et al.
2009; Fromme et al. 2010) in addition to contamination
along life mainly through food chain, ingested dust or
other food contacts.
OCPs were intensively produced for agriculture between
1940s and 1980s, before restrictions and bans due to their
toxic and persistent characteristics in soil and food. PCBs
were intensively produced between 1930s and 1980s
for electrical isolation, lubrication and non-flammable
capacities for various electrical and mechanic applications.
Their persistence in soil and food is mainly due to
contaminations from plants and inadequate disposal
procedures. Their distinctive status (dl or ndl) refers to
their biological mode of action on hormonal receptors,
the first one mimicking that of dioxins. Dioxins are
non-intentionally issued from waste incineration or
some industrial processes like wood and paper, metallurgy,
polyvinyl chloride (PVC) or pesticide synthesis. Despite
progressive substitutions, BFRs are currently used for their
flame retardant abilities in electronic devices as well as
various furnishing materials including carpets and
paintings. PFAS are commonly used as an anti-sticking
material for cooking equipment, anti-stain treatment for
textiles and surfactants in cleaning and cosmetic products.
Dogs live in the same general environment as humans,
both urban and rural, whilst escaping the influence of
certain carcinogens which are already formally recognized
in humans, such as active smoking, alcoholic beverages or
professional exposures. The limited genetic diversity seen
in purebred dogs is expected to facilitate association
studies on relatively small populations. Furthermore, the
time-window for chemical exposure characterization
should be closer to cancer induction and latency in dogs
due to their shorter lifespan (about 10 years at diagnostic)
and may give the opportunity of monitoring canine cohorts
throughout the entire life, after however some essential
issues have been solved. In this study, we monitored for
the first time a large panel of POPs in companion dogsdiagnosed for mammary cancers compared to control
animals, in order to evaluate if the canine spontaneous
model of breast cancer is able to produce results relevant to
human, in a context of comparative etiology and oncology.
1. Methods
1.1. Canine population
115 female pet dogs were recruited between 2012
and 2013 in the Veterinary Hospital Center of Oniris
(Nantes, France). Serum (1 ml) and subcutaneous
adipose tissue (1 gram) sampling were realized during
usual surgery procedures. Pet dogs have been treated
humanely, and their participation during usual surgery
care did not occur until informed consent of owner was
obtained. Inclusion criteria were bitches aged over 4 years;
exclusion criteria were neoplastic diseases other than
breast, mammary dysplasia or hyperplasia (because of their
unknown benign or malign outcome), and chemotherapy
previous sampling. An epidemiological questionnaire was
associated to each canine individual and these data were
available in 90% of cases.
All these 115 dogs were used to evaluate POPs internal
level of exposure in the canine population. Then, subgroups
of “cancer cases” and “controls” were constituted. Cases
were 54 mammary cancers (90% adenocarcinoma, 5%
malignant myoepithelia, 5% sarcoma) and controls were
composed of 30 benign mammary tumors (100% adenoma),
whether or not combined with 17 healthy dogs (checked
for absence of any neoplastic diseases).
1. 2. Targeted substances
115 adipose tissues samples were analyzed for dioxins,
PCBs, OCPs and BFRs. Dioxins analyzed are the 17
PCDD/F congeners regulated by the European Union
(EC/1259/2011). Within PCB congeners, 12 are dl-PCBs
(#77; 81; 105; 114; 118; 123; 126; 156; 157; 167; 169; 189)
and 6 are ndl-PCBs (#28; 52; 101; 138; 153; 180). OCPs
comprise 30 compounds (or metabolites of pesticides)
listed for the majority in the Stockholm convention
(pentachlorobenzene, HCB, α-HCH, β-HCH, γ-HCH
(=lindane), δ-HCH, heptachlor, heptachlor epoxide
cis (=exo B), heptachlor epoxide trans (=endo A),
γ-chlordane (=trans), α-chlordane (=cis), trans-nonachlor,
cis-nonachlor, oxychlordane, aldrin, dieldrin, endrin,
endrin aldehyde, endrin ketone, α-endosulfan, β-endosulfan,
endosulfan sulfate, mirex (=perchlordecone), o,p’-DDE,
p,p’-DDE, o,p’-DDD, p,p’-DDD, o,p’-DDT, p,p’-DDT,
methoxychlor). BFRs include α, β, γ −HBCD isomers
and 8 PBDE congeners (#-28, − 47, − 99, − 100, −
153, − 154, − 183 and – 209).
62 canine serum samples were also analyzed for PFAS,
among which 5 perfluoroalkyl sulfonates: perfluorooctane
sulfonate (PFOS), perfluorobutane sulfonate (PFBS),
perfluorohexane sulfonate (PFHxS), perfluoroheptane
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and 11 perfluorocarboxylic acids: perfluorooctanoic acid
(PFOA), perfluorobutanoic acid (PFBA), perfluoropentanoic
acid (PFPA) perfluorohexanoic acid (PFHxA), perfluoro-
heptanoic acid (PFHpA), perfluorononanoic acid (PFNA),
perfluorodecanoic acid (PFDA), perfluoroundecanoic acid
(PFUnA), perfluorododecanoic acid (PFDoA), perfluorotri-
decanoic acid (PFTrDA) and perfluorotetradecanoic acid
(PFTeDA).1.3 Chemical analysis
1.3.1. Sample preparation
Samples were transferred into individual cells in order to
extract fat content by Accelerated Solvent Extraction
(ASE) using a Dionex ASE 300 device. Pressure and
temperature were set to 100 bars and 120°C respectively.
The sample lipid weight (l.w. in % of wet weight) was
calculated after using a rotary evaporation (40°C). After
ASE, samples were divided into aliquots for targeting
specific chemical substances. 13C-labelled analogues were
added for quantification by the isotope dilution method.
For PCBs, PCDD/Fs and brominated flame retardants,
purification and fractionation are performed in three stages
involving silica, Florisil and charcoal–celite columns.
For organochlorine pesticides, a gel permeation chroma-
tography was preferred to the three stages columns. For
perfluoroalkyl acids, two consecutive solid-phase extraction
(SPE) columns were used. A recovery standard was added
to each vial for each class of compounds.1.3.2. Instrumentation
PCDD/F, PBDE, PCB and OC pesticides measurements
were performed by gas chromatography coupled to
high resolution mass spectrometry (GC-HRMS) using
a 7890A gas chromatograph (Agilent) coupled to a JMS
700D magnetic and electric sector high resolution mass
spectrometer (Jeol, Tokyo, Japan). Ionization was achieved
in the electron ionization mode with 42 electron energy
(eV), except for decaBDE and OC pesticides (70ev). The
spectrometric resolution was set at 10,000 (10% valley),
and the signal acquisition was performed in the Single Ion
Monitoring (SIM) mode focusing on the two most
abundant signals from each target molecular ion, or
two fragment ions for OC pesticides.
HBCD and PFAS analyses were performed by liquid
chromatography coupled to tandem mass spectrometry
(LC-MS/MS) using an HPLC pump with a binary
gradient system (Agilent Technologies, Santa Clara,
CA, USA) coupled to a 6410 triple quadrupole instrument
(Agilent Technologies, Santa Clara, CA, USA). Two
diagnostic signals (qualifier and quantifier MRM tran-
sition respectively) were monitored for each target
compound.1.3.3. Limits of detection
Limits of detection (LOD) were calculated for each
congener and each sample, and corresponded to the
concentration characterized by a Signal/Noise ratio of
3. Procedural blank and quality control samples were
included in each series of ten to twenty samples: the
signal of each compound in the blanks was checked to
avoid contamination throughout the analytical procedure,
and concentrations of analytes in quality control were
monitored to ensure repeatability and/or accuracy.
1.4. Statistical analysis
Results were expressed either as a sum of congeners for
each chemical family, or by congener, in nanogram (ng) or
picogram (pg) per gram of lipid weight (l.w.) extracted
from adipose tissue or serum samples. For PCDD/F and
dl-PCB compounds, Toxic Equivalents (TEQ) were also
calculated according to the World Health Organization
Toxic Equivalency Factors (WHO2005 TEFs). Considering
the independence of canine subgroups, the number of
dogs in a block (n ≥ 30) and the non-normal distribu-
tion of values, Mann-Whitney was used as a non-
parametric statistical test to compare characteristics and
results by pair in a case/control study. Differences with
p-values <0.05 were considered as significant.
1.5 Ethical standards
115 client-owned mammary tumor-bearing or healthy
female dogs were enrolled in this study. The owners’
written consent and approval from the Oniris College of
Veterinary Medicine local Animal Welfare Committee
were obtained prior to inclusion.
2. Results
2.1. Epidemiological characteristics of the canine
population
For the entire group of 115 female dogs, breeds were
distributed in: 15% Retrievers, 15% Yorkshire, 9% others
Terriers (West Highland White, Dandie, Fox, Wheaten
terriers), 8% Spaniels, 6% German Shepherds, 5%
Beauceron, Poodle and Dachshunds, 4% Beagle, Boxer
and Lhassa Apso, 3% Doberman pinsher and Shar Peï,
14% crossed breed. Age ranged from 4 to 17 years old
(mean = 11 +/- 3). Mean weight was 17.6 kg with a
standard deviation of 11.2, a minimum of 1.5 and a
maximum of 41.2. Canine body mass index (BMI)
was estimated on scale from 1 (morbid thin) to 9
(morbid obesity), and the average score for the popu-
lation was 5 (normal). Dog food was mainly dry food
originated from various supermarket brands (including
food industry by-products and fishmeal), supplemented by
part of human food for 70% of dogs. Regarding the places
where the dogs live, about 54% of dogs were coming
from countryside, 30% from urban areas and 16%
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were declared to have no or scarce activity (0-1h of walk
per week), 22% had moderate outdoor activity (1-2h), 23%
had regular outdoor activity (2-5h) and 15% had intensive
outdoor activity (>5h, including hunting).
Characteristics of each subgroup used in the case/
control study (Table 1) were very similar to those of
the entire group and do not constitute confounding
factors, except for overrepresentation of preventiveTable 1 Epidemiological characteristics of « Mammary cancer
tumor » dog subgroups (Difference with p-value >0.05 is non
Characteristics 54 Cancer(a) 47 Non cancer(
Characteristics Mean ± SD Mean ± SD
Age (year) 10 ± 2.7 10 ± 2.5
Weight (kg) 16.9 ± 14.4 18.5 ± 11.6
Canine equivalent for BMI 5.5 ± 1.4 5.4 ± 1.1
Lipids % in sample 57.6 ± 15.3 58.8 ± 15.9
Lipids weight in sample (g) 0.711 ± 0.350 0.698 ± 0.353
Other characteristics Frequency Frequency
Physical activity (per week)
▪ 0-1h 47% 27%
▪ 1-2h 23% 21%
▪ 2-5h 18% 30%
▪ >5h 12% 22%
Pet food
▪ Supermarket 83% 85%
▪ Veterinary 17% 15%
▪ Dry food 72% 73%
▪ Humid food 28% 27%
▪ + Leftovers 71% 70%
Living place
▪ Countryside 56% 52%
▪ Urban area 23% 33%
▪ Downtown 21% 15%
Smoking owner
▪ No smoker 68% 73%
▪ Outside 20% 18%
▪ Inside 12% 9%
Number of litter
▪ 0 72% 64%
▪ 1 13% 17%





dMammary cancer vs. Non cancer.
eMammary cancer vs. Benign mammary tumors.ovariectomy in healthy dogs, compared to cancer or
to controls bearing benign mammary tumors. For this
reason in order to avoid a potential bias, subsequent
statistical analyses were performed using both control
groups in parallel. A deficit for physical activity was
also observed in the cancer group, but no significant
difference was noticed nor for BMI, neither for the
lipid content in samples (Table 1). Physical activity is
further checked.» versus « Non cancer » or « Benign mammary
-significant)
b) 30 Benign tumor(c)
p-value(d) Mean ± SD p-value(e)
0.104 10 ± 2.5 0.185
0.282 15.1 ± 10.4 0.275
0.714 5.5 ± 1.3 0.780
0.613 58.6 ± 15.3 0.835
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All the targeted chemical families were detected in the
studied dogs (Table 2). The 17 targeted PCDD/F congeners
reach an approximate cumulative level ranging from 4 to
278 pg/g l.w. (median = 16 pg/g l.w.). The cumulated
concentration levels of the 12 dl-PCB congeners ranged
from 201 to 15777 pg/g l.w. (median = 830 pg/g l.w.).
Considered together, the 17 PCDD/F and 12 dl-PCB
congeners lead to a toxic equivalent value (WHO
2005 TEQ) of 0.5 pg/g l.w. (min. 0.1 – max 4.1), which
represents a conventional way to evaluate the cumulated
level of toxicity for these particular two chemical families.Table 2 Quantitative determinants of internal exposure and r
dl-PCBs, ndl-PCBs, OCPs, BFRs and PFAS in dogs
Chemical family n Minimum Maximum
Dioxins 115 3.57 pg/g 278.29 pg/g
dl-PCBs 115 201.07 pg/g 15776.67 pg/g
ndl-PCBs 115 0.78 ng/g 99.52 ng/g
OCPs 94 0.50 ng/g 63.92 ng/g
BFRs 115 1.63 ng/g 272.95 ng/g
PFAs 62 0.50 ng/ml 30.81 ng/mlIn terms of frequency, the less abundant congeners that
are supposed to be the most toxic congeners among these
specific substances were detected in at least 86% of dogs.
The cumulated concentration levels of the 6 ndl-PCB
congeners ranged from 0.8 to 99.5 ng/g l.w. (median =
4.3 ng/g l.w.). The 30 targeted OCPs reach a median cu-
mulated level of 5.3 ng/g l.w., with a minimum of 0.5
and a maximum of 63.9. The most abundant pesticides
found in dogs are hexachlorocyclohexane (HCH) isomers
(67% of total), followed by oxychlordane (13%) and
dieldrin (10%). Other significant compounds are hexachlo-
robenzene (HCB), pentachlorobenzene and cis-heptachlorelative contribution of main congeners for dioxins,
25-75% Median Main congeners
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related metabolites were detected in this canine population.
The concentration levels of BFRs vary from 1.6 to 273 ng/g
l.w., with a median value of 16.9 and a partition in 90% of
PBDEs and 10% of HBCDs, approximately. Highly bromi-
nated PBDE-209 represents around 85% of the total BFR
contamination, whereas lower brominated PBDE congeners
(#28, 47, 99, 100, 153, 154 and 183) accounted for only 5%.
The concentration levels of PFAS in serum samples varies
from 0.5 to 30.8 ng/ml l.w., with a median value of 4.9 and
a general partition in 74% of perfluoroalkyl sulfonates and
26% of perfluorocarboxylic acids.
Bioaccumulation properties linked to the age are also
demonstrated (Figure 1).
2.3. Significant features in case-control study of canine
mammary cancer
Subgroups of pet dogs with similar number of individ-
uals and balanced epidemiological criteria were se-
lected. Hence, 54 breast cancers versus 47 no cancer
controls were submitted to non-parametric statistical
analyses (Mann-Whitney test). 54 breast cancers ver-
sus 30 mammary benign tumors were also compared
(Table 1). When pollutants are considered together as a
toxic equivalent value or as a total amount of congeners,
no significant difference is observed inter-groups. How-
ever, when statistical analyses are performed for individual
molecules, significant differences inside the dl-PCB family
restricted to congeners with a non-coplanar chemical
structure (mono-ortho type) are found. Notably, PCB-118
and PCB-156 appear almost twice more concentrated inFigure 1 Trends of bioaccumulation with age in dogs for (a) dioxins,cancer group (median values) than in control groups and
these features seem robust when different populations are
compared (Table 3). Significant differences observed
for PCB-105, PCB-114 and PCB-167 appear group
dependant, understanding that Mann-Whitney test
tends to generate false negative results. Excluding
PCB-167, this shift towards a higher dl-PCB profile
seems not due to atypical individuals amongst cancer
group but seems rather to correspond to a continuum, as
demonstrated by the repartition of cases or controls as a
function of dl-PCB concentrations (Figure 2, Table 4).
Lastly we can assume on the one hand that all breast
cancer cases are probably not related to this chemical
exposure, and on the other hand that some of controls
may further develop the disease, which is adequate to
explain some overlapping measurement points (Figure 3).
When focusing on these congeners regardless the dogs’
pathological status but regarding their physical activity as
a hypothetic bias, no significant difference were noticed
that could mimetic and explain this profile (Table 5).
None of the other 88 molecules among the other five
chemical families (dioxins, ndl-PCBs, OCPs, BFRs and
PFAS) appeared individually associated to mammary
cancer, and multivariate analyses did not reveal any
synergistic mixture effect.
3. Discussion
This innovating project was dedicated to the evaluation
of mammary cancer pet dogs in the perspective of an
epidemiological model to investigate a potential link
between environmental chemical exposure and breast(b) dl-PCBs, (c) ndl-PCBs, (d) PBDEs.
Table 3 Significant POPs associated to canine mammary cancer
Comparative values
(p-value <0.05 is significant)
Relative contribution TEF2005 Median quantity (pg/g l.w.) Median quantity (pg/g l.w.) p-value (Mann- Whitney) Fold-change
Cancer dogs Non cancer
(n =54) dogs (n = 47)
PCB-118 36% 0.00003 359.72 182.89 0.022 1.97
PCB-156 26% 0.00003 271.73 149.28 0.020 1.82
PCB-105 7% 0.00003 56.55 28.40 0.043 1.99
Cancer dogs Benign tumors
(n =54) (n =30)
PCB-118 36% 0.00003 359.72 182.15 0.020 1.97
PCB-156 26% 0.00003 271.73 133.56 0.017 2.03
PCB-114 1.5% 0.0005 15.43 8.33 0.044 1.85
PCB-167 2% 0.00001 9.28 7.66 0.048 1.21
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some dl-PCB congeners characterized by a mono-ortho
structure, namely PCB-118, PCB-156, PCB-105 and
PCB-114, as possible candidate markers associated to
this pathology. These compounds have already been
pointed out in several epidemiological studies focusing on
human breast cancer. According to these studies: pre-
menopausal women associated to a higher level of
PCB-118, PCB-156 and PCB-105 are between two andFigure 2 Distribution of cancer and control cases depending on the cthree times more likely to develop breast cancer than to
be healthy without mammary lesion and without any
history of cancer (Demers et al. 2002), whereas such
a trend was not noticed in menopause women
(Demers et al. 2002; Raaschou-Nielsen et al. 2005;
Rusiecki et al. 2004); women associated to a higher
level of PCB-118 or PCB-105 are about three times
more likely to develop breast cancer than benign
breast tumor (Aronson et al. 2000); women associatedoncentration of dl-PCB congeners, grouped into quartiles.
Table 4 Quartiles of concentrations (pg/g l.w.) for significant dl-PCB congeners established from all dogs (n = 115)
pg/g l.w. Q1 Q2 Q3 Q4
Minimum - 25% 25% - Median Median - 75% 75% - Maximum
PCB-118 40.3-135.3 135.3-254.4 254.4-540.8 540.8-3910.0
PCB-156 40.7-110.3 110.3-196.6 196.6-404.9 404.9-2742.8
PCB-105 6.0-22.8 22.8-45.7 45.7-90.8 90.8-739.6
PCB-114 1.7-5.9 5.9-12.9 12.9-23.8 23.8-235.7
PCB-167 1.6-5.1 5.1-8.9 8.9-17.1 17.1-1389.4
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four times more likely to develop ER-negative breast
cancer subtype than benign breast tumor, whereas
such a trend was not noticed in ER-positive subtype
(Woolcott et al. 2001); women associated to a higher
level of PCB-118 are between three and four times
more likely to develop breast cancer recurrence than to be
cured 5 years after resection (Muscat et al. 2003). In these
studies like in ours, no significant result was observed
considering the total concentration of POPs and the TEQ
values. Significant features were generally found from
specific congeners in particular subgroups of women
especially linked to hormonal status or disease outcome,Figure 3 Distribution of the measurement points represented by “Bo
versus benign tumor cases for PCB-118, PCB-156, PCB-105, PCB-114 aand the statistical power of such restricted population is
often a limit to establish clear evidences on etiology or
pathogenesis. Numerous polymorphisms on cytochrome
P450 (CYP) genes encoding for enzymes playing a key role
in the metabolic breakdown of environmental chemicals
do exist, which can explain distinctive qualitative profiles
of dl-PCB congeners in individuals, despite these mole-
cules were originated from standard industrial mixtures
(Aroclors) at baseline (Lind et al. 2014). Some of these
P450 polymorphisms have been related to breast cancer
(Masson et al. 2005). Furthermore, cumulative POP calcu-
lations (based on linear dose-response relationships in
toxicological models) are relevant for assess overall levelsx and whisker” plots with a confidence interval of 95% in cancer
nd PCB-167.
Table 5 Absence of bias for outdoor physical activity in dl-PCB profiles associated to mammary cancer (p-value >0.05
is non-significant)
Median (pg/g l.w.)
All dogs Regular or intensive activity ≥ 2h/ week No or scarce activity ≤ 1h/ week p-valuec
(n = 115) (n = 39)a (n = 39)b (Mann- Whitney)
PCB-118 254.4 309.2 252.0 0.430
PCB-156 196.6 212.5 196.6 0.343
PCB-105 45.7 47.0 44.1 0.310
PCB-114 12.9 12.7 10.9 0.284
PCB-167 8.9 9.4 8.5 0.211
aDogs with regular or intense activity.
bDogs with no or scarce activity.
cDogs with regular or intense activity vs. Dogs with no or scarce activity.
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the balanced biological responses resulting from competi-
tive binding of numerous exogeneous and endogenous
ligands on the AhR in a regulated physiological system
(Nebert and Karp 2008; Hao and Whitelaw 2013), as one
pollutant can oppose or orientate the effects of the others
(Gregoraszczuk et al. 2008; Ohura et al. 2010).
From a mechanistic point of view in the biology of
cancer and especially breast cancer, dl-PCB congeners
target mainly the AhR, which has been demonstrated to
cross-talk with ER signaling (Ohtake et al. 2011) and
both might down-regulate breast tumor proliferation by
this way and promote tumor escape by ER-negative
phenotype expression (Feng et al. 2013). Independently,
the AhR interacts also with various oncogenic pathways
including those related to the tumor microenvironment
such as alteration of extracellular matrix remodeling,
promotion of angiogenesis and modulation of inflammation
(Feng et al. 2013). These fundamental findings are in
accordance with our results suggesting a role for dl-PCB
congeners in promoting oncogenesis rather than in
initiating mammary lesions, when comparing malignant
and benign tumors. Those findings are also in total
accordance with clinical data obtained in breast cancer
patients: indeed RT-PCR analyses provide evidence that
AhR genes are frequently deregulated (Dialyna et al. 2001);
its repressor molecule AhRR is also frequently down-
regulated by DNA hypermethylation gene silencing
(Zudaire et al. 2008); immunohistochemical staining reveals
that high levels of AhR is detected in mammary epithelial
cells for 87% of the premenopausal breast cancer patients
and may contribute to the ER-negative phenotype,
whereas the same pattern is not observed in benign
tumors (Bidgoli et al. 2010).
All POPs in canine samples were measured at levels
largely lower than those reported for human biomonitoring
and despite this, the same candidate markers were
associated to breast cancer with approximately the
same fold-change inter-groups. A focus on dl-PCBcongeners - namely PCB-118 and PCB-156 - indicates
that their respective concentrations are between 70-150
and 40-80 times less in French dogs (aged 10) in our study
than in US or Canadian women (aged 60) at the time of
breast cancer diagnosis in studies cited above. However
the relative contribution of PCB-118 and PCB-156 inside
the dl-PCB family seems more or less conserved between
these two species when the whole list of congeners is
quantified (Fernandez et al. 2008). This fact supports a
major influence of polymorphisms and power balance
through competitive binding rather than a toxic critical
threshold, unless if the disruption occurred in the womb
owing to a similar level of exposure in utero that has
changed with age, or unless if the sensitivity of dogs to
these molecules is stronger than in humans. Indeed,
relative potencies of dioxins and PCBs (TEF values)
established from rodents and used by extension for
human biomonitoring may turn to be in fact species and
congener specific (Sutter et al. 2010). P450 polymorphisms
may also exist inter-species. For instance, an intriguing
phenomenon is the incapacity of dogs to store any isomers
or metabolites of DDT pesticide in all its known forms
(o,p’-DDE, p,p’-DDE, o,p’-DDD, p,p’-DDD, o,p’-DDT,
p,p’-DDT), whereas p,p’-DDE appears as the main OCP
contribution in humans without clearly interfering with
breast cancer (Ingber et al. 2013). This canine metabolic
specificity that we confirm was established in previ-
ous studies performed in Japan, Italy and Pakistan
(Kunisue et al. 2005; Storelli et al. 2009; Ali et al. 2013),
despite proven petfood contamination. Finally, PCBs
hydroxylation ratio (OH-PCBs/PCBs), which is rarely
targeted in epidemiological studies, varies also widely in
human individuals and in diverse species (Fernandez et al.
2008; Kunisue and Tanabe 2009). This way of interpreting
environmental links to breast cancer with the dog model
may lead to suggest that decreasing exposure thanks to
environmental protective actions may not be effective
straight away for human beings, but tends also to suggest
that if any, biological effect on breast cancer pathology
Sévère et al. SpringerPlus  (2015) 4:27 Page 10 of 11might be reversible by targeting the AhR (Powell et al.
2013; Safe et al. 2013).
4. Conclusions
This study is the first one that evaluates cancer-bearing
companion dogs in the perspective of an epidemiological
model, in order to investigate a potential link between
environmental chemical exposure and breast cancer inci-
dence. We identified pollutants in the dl-PCB family that
were already pointed out in several human epidemiological
studies on breast cancer (i.e. PCB-118, -156, -105, -114).
No significant feature was observed in the other targeted
chemical families (dioxins, ndl-PCB, OCPs, BFRs and PFAS).
Further biological investigations are required ex vivo
to determine if this discrete but recurrent signature
could be associated with the etiology and pathogenesis of
breast cancer subtypes, or appears as a marker without a
role. Such problematic is the same in canine or in human
breast cancer.
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